Skip Navigation

Strengthening the evidence for maternal and child health programs

Find Established Evidence


Displaying records 1 through 4 (4 total).

Adams EK, Kenney GM, Galactionova K. Preventive and reproductive health services for women: the role of California’s family planning waiver. Am J Health Promot. 2013;27(3 Suppl):eS1-eS10.

Link: https://www.ncbi.nlm.nih.gov/pubmed/23286651

NPM: 1: Well-Woman Visit
Intervention Components (click on component to see a list of all articles that use that intervention): PAYER, Expanded Insurance Coverage

Intervention Results:

  • No significant differences in Pap smear rates between women before and after implementation of Medicaid waiver
  • No significant differences in Pap smear rates between women in California and those in comparison states

Wright BJ, Conlin AK, Allen HL, Tsui J, Carlson MJ, Li HF. What does Medicaid expansion mean for cancer and prevention? Results from a randomized trial on the impacts of acquiring Medicaid coverage. Cancer. 2016;122(5):791-7.

Link: https://www.ncbi.nlm.nih.gov/pubmed/26650571

NPM: 1: Well-Woman Visit
Intervention Components (click on component to see a list of all articles that use that intervention): PAYER, Expanded Insurance Coverage

Intervention Results:

  • Significantly higher percentage of Pap tests in the intervention group compared to the control group at 12 months post intervention (19 % difference; P< .015)
  • No significant differences in HPV vaccination between intervention and control groups among the total longitudinal panel at 12 months post intervention.
  • Significantly higher percentage of HPV vaccination in the intervention group compared to the control group within the elevated risk subpanel at 12 months post intervention (4% difference; P< .004)
  • There was little evidence found that acquiring Medicaid increased the adoption of preventive health behaviors that might reduce cancer risk.

Sabik LM, Bradley CJ. The impact of near-universal insurance coverage on breast and cervical cancer screening: evidence from Massachusetts. Health Econ. 2016;25(4):391-401.

Link: https://www.ncbi.nlm.nih.gov/pubmed/25693869

NPM: 1: Well-Woman Visit
Intervention Components (click on component to see a list of all articles that use that intervention): PAYER, Expanded Insurance Coverage

Intervention Results:

Significant increase in number of Pap tests (~5%) in difference in difference estimates from pre-reform to post-reform in Massachusetts

Lipton BJ, Decker SL. ACA provisions associated with increase in percentage of young adult women initiating and completing the HPV vaccine. Health Affairs. 2015;34(5):757-764.

Link: https://www.healthaffairs.org/doi/abs/10.1377/hlthaff.2014.1302

NPM: 1: Well-Woman Visit
Intervention Components (click on component to see a list of all articles that use that intervention): PAYER, Expanded Insurance Coverage, Cost-Sharing Requirements

Intervention Results:

  • Significantly higher percentage of HPV vaccine initiation among women aged 19-25 post intervention compared to pre-intervention (6.83% difference; P<.05).
  • No significant change in percentage of HPV vaccine initiation among the control group of women aged 18 or 26 post intervention compared to pre-intervention.
  • Significantly higher percentage of HPV vaccine initiation among women ages 19-25 compared to a control group of women age 18 or 26 post intervention (7.7 % difference; P<.01).
   

This project is supported by the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) under grant number U02MC31613, MCH Advanced Education Policy, $3.5 M. This information or content and conclusions are those of the author and should not be construed as the official position or policy of, nor should any endorsements be inferred by HRSA, HHS or the U.S. Government.